Porsolt has bought non-animal preclinical testing firm Fluofarma
Preclinical CRO Porsolt has bought cell-based assay developer Fluofarma to increase its non-animal drug screening capacity.
Preclinical CRO Porsolt has bought cell-based assay developer Fluofarma to increase its non-animal drug screening capacity.
Almost half of all manufacturers have reported production downtime resulting from barcode labelling problems, according to a new survey.